Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Vormehr

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Nature|April 23, 2015
Mutant MHC class II epitopes drive therapeutic immune responses to cancerSebastian Kreiter, Mathias Vormehr, Niels van de Roemer, et al.
Nature|June 5, 2015
Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancerSebastian Kreiter, Mathias Vormehr, Niels van de Roemer, et al.
Oncoimmunology|February 7, 2019
A non-functional neoepitope specific CD8<sup>+</sup> T-cell response induced by tumor derived antigen exposure <i>in vivo</i>Mathias Vormehr, Katharina Reinhard, Renata Blatnik, et al.
Gastroenterology|October 3, 2020
Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in MiceBernd Heinrich, Zachary J Brown, Laurence P Diggs, et al.
Oncoimmunology|February 21, 2022
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulationAlexander Muik, Isil Altintas, Friederike Gieseke, et al.
Nature|June 10, 2016
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyLena M Kranz, Mustafa Diken, Heinrich Haas, et al.
Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.
Nature|January 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature|September 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature|July 6, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerUgur Sahin, Evelyna Derhovanessian, Matthias Miller, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Nature|April 23, 2015
Mutant MHC class II epitopes drive therapeutic immune responses to cancerSebastian Kreiter, Mathias Vormehr, Niels van de Roemer, et al.
Nature|June 5, 2015
Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancerSebastian Kreiter, Mathias Vormehr, Niels van de Roemer, et al.
Oncoimmunology|February 7, 2019
A non-functional neoepitope specific CD8<sup>+</sup> T-cell response induced by tumor derived antigen exposure <i>in vivo</i>Mathias Vormehr, Katharina Reinhard, Renata Blatnik, et al.
Gastroenterology|October 3, 2020
Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in MiceBernd Heinrich, Zachary J Brown, Laurence P Diggs, et al.
Oncoimmunology|February 21, 2022
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulationAlexander Muik, Isil Altintas, Friederike Gieseke, et al.
Nature|June 10, 2016
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapyLena M Kranz, Mustafa Diken, Heinrich Haas, et al.
Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.
Nature|January 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature|September 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature|July 6, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerUgur Sahin, Evelyna Derhovanessian, Matthias Miller, et al.
Pageof 4